Arrowhead Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arrowhead Pharma using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q1 | 2025-02-10 | $-1.39 | $-0.72 | -93.1 % |
Q4 | 2024-11-26 | $-1.37 | $-0.92 | -48.9 % |
Q3 | 2024-08-08 | $-1.38 | $-0.55 | -150.9 % |
Q2 | 2024-05-09 | $-1.02 | $-0.16 | -537.5 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q1 | 2025-02-10 | $2.50M | $19.05M | -86.9 % |
Q4 | 2024-11-26 | $0 | $58.91M | -100.0 % |
Q3 | 2024-08-08 | $0 | $52.63M | -100.0 % |
Q1 | 2024-02-06 | $3.55M | $29.51M | -88.0 % |
Arrowhead Pharma (ARWR) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 10, 2025 for Q1.
The Actual EPS was $-1.39, which missed the estimate of $-0.72.
The Actual Revenue was $2.5M, which missed the estimate of $19.1M.
Browse earnings estimates, EPS, and revenue on all stocks.